Are topical nonsteroidal anti-inflammatory drugs (NSAIDs) safe and effective for knee osteoarthritis?

Topical NSAIDs for Knee Arthritis: Safety and Efficacy

Topical NSAIDs are both safe and beneficial for knee osteoarthritis and should be strongly recommended as first-line pharmacological therapy, particularly for patients over 75 years or those with gastrointestinal, cardiovascular, or renal comorbidities. 1, 2

Evidence Quality and Strength

The most recent and highest-quality evidence comes from the 2020 ACR/Arthritis Foundation guideline, which provides a strong recommendation for topical NSAIDs specifically for knee OA 1. This represents the strongest level of endorsement in contemporary guidelines and supersedes older recommendations.

Efficacy Profile

Pain Relief:

• Topical NSAIDs demonstrate moderate effect sizes for pain reduction (standardized mean difference 0.365) compared to placebo 3
• Approximately 60% of patients achieve substantial pain relief with topical diclofenac or ketoprofen 4
• Topical NSAIDs are equally effective as oral NSAIDs for knee OA pain and function improvement 3, 5

Specific Agents:

• Topical diclofenac (70-81 mg/day) is the most rigorously studied and should be considered the preferred agent 5, 6
• Topical ketoprofen also demonstrates strong efficacy with NNT of 6.9 for clinical success 7
• Diclofenac is the only topical NSAID approved for over-the-counter use in the US 6

Safety Advantages

Superior Safety Profile:

• Markedly fewer gastrointestinal adverse events compared to oral NSAIDs due to reduced systemic absorption 5, 8
• Local skin reactions (mild) are the primary adverse events, occurring more frequently than placebo but representing minimal clinical concern 4
• No increase in serious systemic adverse events compared to carrier 4

Key Safety Considerations:

• Formulation matters: patches or DMSO-containing carriers have higher adverse event rates than standard gel formulations 6
• Long-term safety data (up to 1 year) confirms consistent safety profile 2, 8

Clinical Algorithm for Use

First-Line Indication:

1. Strongly recommend topical NSAIDs for:

   • All patients with knee OA requiring pharmacological therapy 1, 2
   • Patients ≥75 years (preferentially over oral NSAIDs) 9, 10
   • Patients with cardiovascular, gastrointestinal, or renal risk factors 11, 8
   • Patients unwilling or unable to take oral NSAIDs 7

2. Specific prescribing:

   • Use topical diclofenac 70-81 mg/day as first choice 5
   • Apply to affected knee(s) 2-4 times daily
   • Trial for 2-4 weeks minimum before assessing efficacy 12
   • Discontinue if ineffective after adequate trial 2

When to Escalate:

• If topical NSAIDs provide insufficient relief after 2-4 weeks, consider adding (not replacing) oral NSAIDs or other modalities 10
• In patients <75 years without comorbidities, oral NSAIDs may be used if topical therapy is inadequate 9

Important Caveats

Limitations:

• Evidence is specific to knee OA only—insufficient data for hip OA due to joint depth 2
• Hand OA has conditional (not strong) recommendations for topical NSAIDs 1
• Carrier/placebo effects are substantial (approximately 50% response rate), but topical NSAIDs add meaningful benefit beyond this 4

Common Pitfall to Avoid: Do not reserve topical NSAIDs only for patients who "fail" oral therapy. Current evidence supports topical NSAIDs as preferred first-line pharmacological treatment for knee OA, ahead of oral NSAIDs, based on the superior benefit-to-risk ratio 1, 2, 5.